Comparative Analysis of Potential Clinical Actionability of Genomic Alterations in Early-Onset Versus Later-Onset GI Cancers

Lawrence W. Wu, Jimyung Park, Sungjoo Jang, Ryan H. Moy

Open source

DOI
10.1200/po-26-00389
Published
2026-08
Container
JCO Precision Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/po-26-00389,
  title = {Comparative Analysis of Potential Clinical Actionability of Genomic Alterations in Early-Onset Versus Later-Onset GI Cancers},
  author = {Lawrence W. Wu and Jimyung Park and Sungjoo Jang and Ryan H. Moy},
  year = {2026},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po-26-00389},
  url = {https://doi.org/10.1200/po-26-00389}
}

RIS

TY  - JOUR
TI  - Comparative Analysis of Potential Clinical Actionability of Genomic Alterations in Early-Onset Versus Later-Onset GI Cancers
AU  - Lawrence W. Wu
AU  - Jimyung Park
AU  - Sungjoo Jang
AU  - Ryan H. Moy
PY  - 2026
JO  - JCO Precision Oncology
DO  - 10.1200/po-26-00389
UR  - https://doi.org/10.1200/po-26-00389
ER  - 

APA

Wu, L. W., Park, J., Jang, S., & Moy, R. H. (2026). Comparative Analysis of Potential Clinical Actionability of Genomic Alterations in Early-Onset Versus Later-Onset GI Cancers. JCO Precision Oncology. https://doi.org/10.1200/po-26-00389

Source records